Naprod Group · Tarapur, India
Building global specialty pharmaceutical platforms.
Five integrated platforms, built on one EU-GMP-accredited site in Tarapur, Maharashtra, and 30+ years of manufacturing under a single quality system.
EU-GMP certified15+ international accreditations200+ products40+ countries
-
30 +
Years of manufacturing
-
12 M
Lyophilized oncology vials / yr
-
200 +
Products
-
15 +
International accreditations
-
40 +
Countries supplied
Formulation · R&D
Research & Development
DOC · R&D-PIPEEvery route begins on the bench. Formulation and analytical development run in-house, feeding a live pipeline that keeps the plant supplied with the next generation of molecules.
- 24products
in pipeline - 16oncology
candidates - 4dosage
forms - 4development
tracks
REF · R&D/24: 24-product development pipeline
Explore R&D /capabilities/research-developmentLyophilization
Lyophilization
CYCLE · LYOWater leaves the vial as crystal, not liquid. Freeze-drying suites hold the lattice intact through primary and secondary drying, stabilizing sensitive injectables for the road ahead.
CYCLE · LYO/NL: 12M lyophilized units per year
Explore lyophilization /capabilities/lyophilizationQuality Release
Quality release · one record
No vial leaves the site without a record. Manufacturing and quality operate under one system, so every batch resolves to one plant, one dossier, one signature.
- Accreditations on the register
- 15+
- Plant of record
- Tarapur · 1
Registration
Accredited by 15+ authorities
REG · STAMPSA batch crosses borders on its accreditations. Each regulator that inspects the site adds its mark to the record. The top five are shown here.
-
EU-GMP Europe -
ANVISA Brazil , Iss · Jan 2026 -
INVIMA Colombia , Iss · 2023 -
EAEU Eurasia , Iss · Jun 2026 -
UAE MOHAP UAE
ANVISA renewed Jan 2026 · the full 15+-entry register lives on the Quality page.
See every stamp /qualityExport
40+ countries across 5 continents
ROUTE · BOMFrom Tarapur to the bedside abroad. Every batch departs on a documented route into 40+ countries across five continents, each market opened by the site's accreditations.
BOM 40+ countries across 5 continents
200+ products 15+ accreditations 1 plant of record
Trace the routes /global-presenceEnd of route
Where do you join the route?
- A / Product Sourcing a molecule Browse the catalogue of 200+ products by therapy area and dosage form, with dossiers built for registration. Explore products /products
- B / Partner Partner with us Contract manufacturing, licensing, and supply from one integrated site with a single quality spine. Explore partnering /partner
- C / Quality Reviewing our record before an audit Open the quality dossier: accreditations, systems, and batch traceability, prepared for inspection. Review the record /quality
The record
Three decades on one site
The company history in the dates that matter: founding, the oncology platform, the certifications that opened each market.
- 1994
Founded, injectable production begins at Boisar
Naprod Life Sciences began production of oncology, anesthesia, and critical-care injectables at Boisar, Maharashtra.
- 2000
Entered the oncology segment
Oncology manufacturing began, the platform the company is now known for.
- 2002
Oncology operations expand, exports begin
Expanded oncology operations and commenced exports to Southeast Asia, Africa, and Latin America.
- 2012
Anesthesia portfolio strengthened through Propofol
Strengthened the anesthesia portfolio through the Propofol business. ANVISA (Brazil) GMP certification received the same year.
- 2015
INVIMA (Colombia) certification
INVIMA GMP certification extended regulated-market access across Latin America.
- 2017
Ukraine certification
Ukraine GMP certification opened supply into the country's regulated market.
- 2019
EU-GMP, entry to the strictest tier
EU-GMP certification for the Tarapur facility, enabling direct supply into European Economic Area markets.
- 2024
First commercial order into the EU
The first commercial order under the EU-GMP certification shipped into the European Union.
- 2026
ANVISA renewal, the standard still holds
ANVISA renewed the Tarapur plant's GMP certification in January 2026, reaffirming continuous Brazilian market access.
Source: Pharma India Magazine, January 2026
APIs and finished dosage sit under one group: active ingredients are supplied through group company MacChem, and finished injectables leave this site.
Meet the leadership /about/leadershipRoute log / News
Verified regulatory news
Naprod publishes a story only once it is confirmable through a named third-party source.
Open roles across the group
Open roles span business development and alliances, CDMO/CMO partnership, regulatory affairs, finance, sourcing, and talent acquisition. Most are at the Mumbai head office, plus a regional Country Manager for Southeast Asia.